Tags

Type your tag names separated by a space and hit enter

LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.
J Travel Med. 2014 Mar-Apr; 21(2):116-29.JT

Abstract

BACKGROUND

Treatment of cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML) in travelers is still controversial. Over the last decade, national and international consortia have published recommendations for treating CL in travelers. These guidelines harmonize many issues, but there are some discrepancies.

METHODS

Leishmania parasites causing CL can now be genotyped by polymerase chain reaction techniques for detecting Leishmania DNA. Therefore, treatment recommendations can now be species based rather than based on geographical exposure. To review the evidence on which the recommendations were based, "LeishMan" (Leishmaniasis Management), a group of experts from 13 institutions in eight European countries, performed a PubMed MEDLINE) literature search and considered unpublished evidence and the experts' own personal experiences. The Oxford evidence grading system was used to evaluate the information.

RESULTS AND CONCLUSION

In this article, the authors provide practical treatment recommendations for imported CL and ML in Europe, drawn up from the review by the European experts.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

24745041

Citation

Blum, Johannes, et al. "LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014." Journal of Travel Medicine, vol. 21, no. 2, 2014, pp. 116-29.
Blum J, Buffet P, Visser L, et al. LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. J Travel Med. 2014;21(2):116-29.
Blum, J., Buffet, P., Visser, L., Harms, G., Bailey, M. S., Caumes, E., Clerinx, J., van Thiel, P. P., Morizot, G., Hatz, C., Dorlo, T. P., & Lockwood, D. N. (2014). LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. Journal of Travel Medicine, 21(2), 116-29.
Blum J, et al. LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014. J Travel Med. 2014 Mar-Apr;21(2):116-29. PubMed PMID: 24745041.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. AU - Blum,Johannes, AU - Buffet,Pierre, AU - Visser,Leo, AU - Harms,Gundel, AU - Bailey,Mark S, AU - Caumes,Eric, AU - Clerinx,Jan, AU - van Thiel,Pieter P A M, AU - Morizot,Gloria, AU - Hatz,Christoph, AU - Dorlo,Thomas P C, AU - Lockwood,Diana N J, PY - 2014/4/19/entrez PY - 2014/4/20/pubmed PY - 2014/11/14/medline SP - 116 EP - 29 JF - Journal of travel medicine JO - J Travel Med VL - 21 IS - 2 N2 - BACKGROUND: Treatment of cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML) in travelers is still controversial. Over the last decade, national and international consortia have published recommendations for treating CL in travelers. These guidelines harmonize many issues, but there are some discrepancies. METHODS: Leishmania parasites causing CL can now be genotyped by polymerase chain reaction techniques for detecting Leishmania DNA. Therefore, treatment recommendations can now be species based rather than based on geographical exposure. To review the evidence on which the recommendations were based, "LeishMan" (Leishmaniasis Management), a group of experts from 13 institutions in eight European countries, performed a PubMed MEDLINE) literature search and considered unpublished evidence and the experts' own personal experiences. The Oxford evidence grading system was used to evaluate the information. RESULTS AND CONCLUSION: In this article, the authors provide practical treatment recommendations for imported CL and ML in Europe, drawn up from the review by the European experts. SN - 1708-8305 UR - https://www.unboundmedicine.com/medline/citation/24745041/full_citation L2 - https://academic.oup.com/jtm/article-lookup/doi/10.1111/jtm.12089 DB - PRIME DP - Unbound Medicine ER -